PIK3C2A and cancer: The 7 categories are the (1) cancer cell viability percentage, (2) IC50 of the cancer cells, (3) tumour volume regression (4) Pt biodistribution concentration in the tumours, (5) Pt biodistribution concentration in the vital organs; (i) heart, (ii) liver, (iii) kidneys, (iv) lungs, (v) spleen, (6) the gain or loss in body weight, and (7) the haematological/inflammatory parameters that indicate biosafety of the nanocarriers; (i) AST, (ii) ALT, (iii) CPK, (iv) BUN, and (v) Creatinine.